Please assess the completion status of the following clinical trial:

Trial Title: Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be 3 to less than 7 years old with amblyopia associated with strabismus, anisometropia, or both.~* Visual acuity in the amblyopic eye must be between 20/40 and 20/400 inclusive, visual acuity in the sound eye 20/40 or better and inter-eye acuity difference \> 3 logMAR lines.~* Spectacles, if needed, must be worn for at least 16 weeks or until visual acuity documented to be stable.~Exclusion Criteria:~* Atropine treatment within 6 months of enrollment and other amblyopia treatment of any type (other than normal spectacle lenses) used within one month of enrollment~* No myopia in amblyopic eye

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- Atropine (Type: ACTIVE_COMPARATOR): Atropine 1% once each weekend day in the sound eye
- Atropine plus plano (Type: ACTIVE_COMPARATOR): Atropine 1% once each weekend day in the sound eye plus a plano lens for the sound eye

Based on this trial design, predict the completion outcome and termination type (if applicable).